Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

India’s Piramal Buys Kentucky Drug Labs

by Michael McCoy
January 26, 2015 | A version of this story appeared in Volume 93, Issue 4

Piramal Enterprises has acquired the contract manufacturer Coldstream Laboratories for $31 million. Founded in 2007 and previously majority owned by the University of Kentucky Research Foundation, Coldstream manufactures sterile liquid and lyophilized finished drugs for clinical trials and commercial use. It had sales of about $14 million last year and claims expertise in high-potency and cytotoxic compounds, including antibody-drug conjugates. Piramal says Coldstream will become part of its contract development and manufacturing unit.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.